Adelaide, Australia, 18 March 2020 – GPN Vaccines is pleased to announce Ms Eve Michelle Martin has been appointed as Company Secretary and General Counsel. Ms Martin will replace Dr Tim Hirst who has resigned as Company Secretary to focus on his role as Chairman & CEO...
Adelaide, Australia, 24 January 2020 – GPN Vaccines announces that it has changed its status from a Private Company limited by shares to a Public Company limited by shares and changed its name to GPN Vaccines Ltd. Shareholders at the Company’s Annual General Meeting held on Tuesday 10th...
Adelaide, Australia, 18 November 2019 – GPN Vaccines is pleased to announce Dr Lauren Giorgio has been appointed as the Company’s Chief Operating Officer. Lauren brings valuable experience in intellectual property management, business development, stakeholder engagement, commercialisation and operations in the life sciences sector, encompassing the...
GPN Vaccines selected as one of eight companies to pitch at the Startup Slam @ BIO-Europe event on 12 Nov 2019 in Hamburg....
Shannon David and Zoe Laan give presentations at the 14th European Meeting on the Molecular Biology of the Pneumococcus in Greifswald, Germany...
Tim Hirst named one of Australia’s top 50 small business leaders 2019 [https://insidesmallbusiness.com.au/planning-management/australias-top-50-small-business-leaders-2019]...